{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:58:32Z","timestamp":1781657912441,"version":"3.54.5"},"reference-count":16,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T00:00:00Z","timestamp":1221523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:\u2002<\/jats:bold> To compare the efficacy of mifepristone and vaginal misoprostol with misoprostol alone for pregnancy termination up to 63 days.<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> This exploratory study was conducted in the Department of Obstetrics and Gynecology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal as a part of a thesis study for a period of one year from April 2005\u20132006. After confirming a pregnancy \u226463 days gestation by transvaginal ultrasound, an equal number of women (50) were randomized into (i) group A, women who received 200\u2003mg oral mifepristone (RU 486) on day 1 and vaginal misoprostol 800\u2003\u00b5g on day 3; and (ii) group B, women who received vaginal misoprostol (800\u2003\u00b5g) on day 1 and 3 (total dose 1600\u2003\u00b5g). The primary study outcome measure was complete abortion without surgical intervention making comparisons between these two groups in terms of complete abortion rate, need for manual vacuum aspiration for incomplete abortion and pregnancy continuation after reconfirming the diagnosis on transvaginal ultrasound, besides comparing the side effects\/complications.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Fewer side effects and a more complete abortion rate (94%) was observed in group A (mifepristone and vaginal misoprostol) in comparison to vaginal misoprostol alone (total dose 1600\u2003\u00b5g) giving a complete abortion rate of 86% along with a significant hematocrit drop on follow\u2010up day 10 (<jats:italic>P<\/jats:italic>\u2003=\u20030.03) besides having increased duration of bleeding (<jats:italic>P\u2003<\/jats:italic>=\u20030.017).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Mifepristone oral (200\u2003mg) followed by vaginal misoprostol (800\u2003\u00b5g) on day 3 provides a better success rate (94%) with fewer complications than vaginal misoprostol 800\u2003\u00b5g used on days 1 and 3 for medical abortion of pregnancies up to 63 days.<\/jats:p>","DOI":"10.1111\/j.1447-0756.2008.00864.x","type":"journal-article","created":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T03:04:45Z","timestamp":1221620685000},"page":"78-85","source":"Crossref","is-referenced-by-count":16,"title":["Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: A quasi\u2010randomized controlled trial"],"prefix":"10.1111","volume":"35","author":[{"given":"Rashmi","family":"Chawdhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashma","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00153.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.10.2962"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.10.2098"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2005.02.019"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/13625180008500394"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2005.00380.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(01)00229-3"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(02)00493-6"},{"key":"e_1_2_6_10_2","first-page":"132","article-title":"Comparison of oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion","volume":"122","author":"Mittal S","year":"2005","journal-title":"Indian J Med Res"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000258298.35143.d2"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000124271.23499.84"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.6.1477"},{"issue":"3","key":"e_1_2_6_14_2","first-page":"127","article-title":"Medical abortion alternatives to mifepristone","volume":"55","author":"Creinin MD","year":"2000","journal-title":"J Am Med Womens Assoc"},{"key":"e_1_2_6_15_2","first-page":"24","article-title":"Antiprogesterone for medical abortion","volume":"135","author":"Khomasuridze AG","year":"2006","journal-title":"Georgian Med News"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.5.1159"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/13625180008500410"}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1447-0756.2008.00864.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1447-0756.2008.00864.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:58:13Z","timestamp":1697327893000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1447-0756.2008.00864.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1447-0756.2008.00864.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1447-0756.2008.00864.x","archive":["Portico"],"relation":{},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}